One-year net survival for each cancer site, by whether each waiting time target was met or not, England, 2009–13.

Methods to estimate national survival for different cancer sites in nations only partially covered by cancer registration.

LILLINI R
M. VERCELLI
QUAGLIA A
MICHELI A
CAPOCACCIA R

January 2006

Methods to estimate national survival for different cancer sites in nations only partially covered b...

Cancer survival in the Strategic Health Authorities of England, 1997-2004

Rachet, Bernard
Coleman, Michel P
Cooper, N
Elgohari, S

January 2006

This dataset presents the latest one- and five-year age-standardised relative survival rates for can...

Cancer survival in the strategic health authorities of England, 1995-2002

Rachet, Bernard
Coleman, Michel P
Cooper, N
Quinn, MJ

January 2005

This dataset contains one- and five-year age-standardised relative survival rates for cancers of the...

One-year net survival for all patients surviving more than 90 days by waiting time intervals, from decision to treat to first treatment, and by stage, England, 2009–13.

Chiara Di Girolamo (5675315)
Sarah Walters (593845)
Carolynn Gildea (5675318)
Sara Benitez Majano (5675321)
Bernard Rachet (835834)
Melanie Morris (1522519)

August 2018

One-year net survival for all patients surviving more than 90 days by waiting time intervals, from d...

Target attainment by patient characteristics for each waiting time target and cancer site, England, 2009–2013.

Chiara Di Girolamo (5675315)
Sarah Walters (593845)
Carolynn Gildea (5675318)
Sara Benitez Majano (5675321)
Bernard Rachet (835834)
Melanie Morris (1522519)

August 2018

Target attainment by patient characteristics for each waiting time target and cancer site, England, ...

Numbers and percentages of cancer patients who were recorded in the cancer waiting times dataset and for whom the waiting time targets can be calculated, England, 2009–2013 (percentages of patients remaining calculated from the total number of the cell above).

Chiara Di Girolamo (5675315)
Sarah Walters (593845)
Carolynn Gildea (5675318)
Sara Benitez Majano (5675321)
Bernard Rachet (835834)
Melanie Morris (1522519)

August 2018

Numbers and percentages of cancer patients who were recorded in the cancer waiting times dataset and...

Time to first treatment (62-day target) by treatment category for cancer patients who survived 90 days after diagnosis, England, 2009–2013.

Chiara Di Girolamo (5675315)
Sarah Walters (593845)
Carolynn Gildea (5675318)
Sara Benitez Majano (5675321)
Bernard Rachet (835834)
Melanie Morris (1522519)

August 2018

Time to first treatment (62-day target) by treatment category for cancer patients who survived 90 da...

Can we assess Cancer Waiting Time targets with cancer survival? A population-based study of individually linked data from the National Cancer Waiting Times monitoring dataset in England, 2009-2013

Chiara Di Girolamo (5675315)
Sarah Walters (593845)
Carolynn Gildea (5675318)
Sara Benitez Majano (5675321)
Bernard Rachet (835834)
Melanie Morris (1522519)

August 2018

BackgroundCancer Waiting Time targets have been integrated into successive cancer strategies as indi...

Can we assess Cancer Waiting Time targets with cancer survival? A population-based study of individually linked data from the National Cancer Waiting Times monitoring dataset in England, 2009-2013.

Chiara Di Girolamo
Sarah Walters
Carolynn Gildea
Sara Benitez Majano
Bernard Rachet
Melanie Morris

January 2018

BACKGROUND:Cancer Waiting Time targets have been integrated into successive cancer strategies as ind...

Cancer survival: five year relative survival rates in England by Health Authority up to 1999 - four further cancer sites

Rachet, Bernard
Coleman, Michel P
Cooper, N
Quinn, M

January 2005

This dataset presents the five-year relative survival rates up to the end of 1999 for those people d...

Cancer survival: five year relative survival rates in England by Health Authority up to 2000 - four further cancer sites

Rachet, Bernard
Coleman, Michel P
Cooper, N
Quinn, M

January 2005

This dataset presents the latest five-year relative survival rates up to the end of 2000 for those p...

Cancer survival: five year relative survival rates in England by Health Authority up to 2000

Rachet, Bernard
Coleman, Michel P
Cooper, N
Quinn, M

January 2005

This dataset presents the latest five-year relative survival rates up to the end of 2000 for those p...

Survival rates in England by Strategic Health Authority up to 2001

Rachet, Bernard
Coleman, Michel P
Cooper, N
Quinn, MJ

January 2005

One- and five-year age-standardised relative survival (%) by strategic health authority, patients di...

Cancer survival: five year relative survival rates in England by Health Authority up to 1999

Rachet, Bernard
Coleman, Michel P
Cooper, N
Quinn, MJ

January 2005

This dataset presents the five-year relative survival rates up to the end of 1999 for those persons ...

Five-year net survival for women with breast cancer according to stage and screening program status, Slovenia 2008–2018.

Sonja Tomšič (14197364)
Tina Žagar (11038649)
Ana Mihor (14197367)
Miran Mlakar (14197370)
Katarina Lokar (14197373)
Katja Jarm (11539889)
Vesna Zadnik (4813149)

November 2022

Five-year net survival for women with breast cancer according to stage and screening program status,...

Methods to estimate national survival for different cancer sites in nations only partially covered by cancer registration.

LILLINI R
M. VERCELLI
QUAGLIA A
MICHELI A
CAPOCACCIA R

January 2006

Methods to estimate national survival for different cancer sites in nations only partially covered b...

Cancer survival in the Strategic Health Authorities of England, 1997-2004

Rachet, Bernard
Coleman, Michel P
Cooper, N
Elgohari, S

January 2006

This dataset presents the latest one- and five-year age-standardised relative survival rates for can...

Cancer survival in the strategic health authorities of England, 1995-2002

Rachet, Bernard
Coleman, Michel P
Cooper, N
Quinn, MJ

January 2005

This dataset contains one- and five-year age-standardised relative survival rates for cancers of the...

One-year net survival for all patients surviving more than 90 days by waiting time intervals, from decision to treat to first treatment, and by stage, England, 2009–13.

Chiara Di Girolamo (5675315)
Sarah Walters (593845)
Carolynn Gildea (5675318)
Sara Benitez Majano (5675321)
Bernard Rachet (835834)
Melanie Morris (1522519)

August 2018

One-year net survival for all patients surviving more than 90 days by waiting time intervals, from d...

Target attainment by patient characteristics for each waiting time target and cancer site, England, 2009–2013.

Chiara Di Girolamo (5675315)
Sarah Walters (593845)
Carolynn Gildea (5675318)
Sara Benitez Majano (5675321)
Bernard Rachet (835834)
Melanie Morris (1522519)

August 2018

Target attainment by patient characteristics for each waiting time target and cancer site, England, ...

Numbers and percentages of cancer patients who were recorded in the cancer waiting times dataset and for whom the waiting time targets can be calculated, England, 2009–2013 (percentages of patients remaining calculated from the total number of the cell above).

Chiara Di Girolamo (5675315)
Sarah Walters (593845)
Carolynn Gildea (5675318)
Sara Benitez Majano (5675321)
Bernard Rachet (835834)
Melanie Morris (1522519)

August 2018

Numbers and percentages of cancer patients who were recorded in the cancer waiting times dataset and...

Time to first treatment (62-day target) by treatment category for cancer patients who survived 90 days after diagnosis, England, 2009–2013.

Chiara Di Girolamo (5675315)
Sarah Walters (593845)
Carolynn Gildea (5675318)
Sara Benitez Majano (5675321)
Bernard Rachet (835834)
Melanie Morris (1522519)

August 2018

Time to first treatment (62-day target) by treatment category for cancer patients who survived 90 da...

Can we assess Cancer Waiting Time targets with cancer survival? A population-based study of individually linked data from the National Cancer Waiting Times monitoring dataset in England, 2009-2013

Chiara Di Girolamo (5675315)
Sarah Walters (593845)
Carolynn Gildea (5675318)
Sara Benitez Majano (5675321)
Bernard Rachet (835834)
Melanie Morris (1522519)

August 2018

BackgroundCancer Waiting Time targets have been integrated into successive cancer strategies as indi...

Can we assess Cancer Waiting Time targets with cancer survival? A population-based study of individually linked data from the National Cancer Waiting Times monitoring dataset in England, 2009-2013.

Chiara Di Girolamo
Sarah Walters
Carolynn Gildea
Sara Benitez Majano
Bernard Rachet
Melanie Morris

January 2018

BACKGROUND:Cancer Waiting Time targets have been integrated into successive cancer strategies as ind...

Cancer survival: five year relative survival rates in England by Health Authority up to 1999 - four further cancer sites

Rachet, Bernard
Coleman, Michel P
Cooper, N
Quinn, M

January 2005

This dataset presents the five-year relative survival rates up to the end of 1999 for those people d...

Cancer survival: five year relative survival rates in England by Health Authority up to 2000 - four further cancer sites

Rachet, Bernard
Coleman, Michel P
Cooper, N
Quinn, M

January 2005

This dataset presents the latest five-year relative survival rates up to the end of 2000 for those p...

Cancer survival: five year relative survival rates in England by Health Authority up to 2000

Rachet, Bernard
Coleman, Michel P
Cooper, N
Quinn, M

January 2005

This dataset presents the latest five-year relative survival rates up to the end of 2000 for those p...

Survival rates in England by Strategic Health Authority up to 2001

Rachet, Bernard
Coleman, Michel P
Cooper, N
Quinn, MJ

January 2005

One- and five-year age-standardised relative survival (%) by strategic health authority, patients di...

Cancer survival: five year relative survival rates in England by Health Authority up to 1999

Rachet, Bernard
Coleman, Michel P
Cooper, N
Quinn, MJ

January 2005

This dataset presents the five-year relative survival rates up to the end of 1999 for those persons ...

Five-year net survival for women with breast cancer according to stage and screening program status, Slovenia 2008–2018.

Sonja Tomšič (14197364)
Tina Žagar (11038649)
Ana Mihor (14197367)
Miran Mlakar (14197370)
Katarina Lokar (14197373)
Katja Jarm (11539889)
Vesna Zadnik (4813149)

November 2022

Five-year net survival for women with breast cancer according to stage and screening program status,...

Methods to estimate national survival for different cancer sites in nations only partially covered by cancer registration.

LILLINI R
M. VERCELLI
QUAGLIA A
MICHELI A
CAPOCACCIA R

January 2006

Methods to estimate national survival for different cancer sites in nations only partially covered b...

Cancer survival in the Strategic Health Authorities of England, 1997-2004

Rachet, Bernard
Coleman, Michel P
Cooper, N
Elgohari, S

January 2006

This dataset presents the latest one- and five-year age-standardised relative survival rates for can...

Cancer survival in the strategic health authorities of England, 1995-2002

Rachet, Bernard
Coleman, Michel P
Cooper, N
Quinn, MJ

January 2005

This dataset contains one- and five-year age-standardised relative survival rates for cancers of the...

One-year net survival for each cancer site, by whether each waiting time target was met or not, England, 2009–13.

Abstract

Extracted data

One-year net survival for each cancer site, by whether each waiting time target was met or not, England, 2009–13.

Abstract

Extracted data

Related items

Related items